S oft tissue sarcomas are the sixth most common malignancy in childhood and rhabdomyosarcot t mas constitute about 50% of soft tissue sarcot t mas. This tumor accounts for 10% to 15% of solid mat t lignant tumors and 6% of all malignancies in children under 15 years of age. In the United States, the malet totfemale ratio is 1.5:1, and the tumor is twice as comt t mon in whites as in AfricantAmericans. Approximately 250 new cases are diagnosed every year.
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Rhabdomyosarcoma is a malignant tumor of strit t ated muscle but, because of its mesenchymal origin, can originate in tissue that does not normally contain striated muscle (for example, the ureter). There is a bit t modal distribution of rhabdomyosarcoma with peaks between 2 and 4 years of age and 12 and 16 years of age. Nearly 80% of rhabdomyosarcoma is diagnosed by the age of 14 years. The most common primary sites for rhabdomyosarcomas include the head and neck, the genitourinary tract, and extremities. However, primary sites with a favorable prognosis include the orbit and nonparameningeal, head and neck, paratestis, the vat t gina, and the biliary tract.
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CASE
A 3tyeartold female had a 6tmonth history of genital swelling. Gynecological examination revealed that she had clitoral swelling. Ultrasound revealed a cystic mass, which was mostly a clitoral cyst. CT of abdomen and chest were free, while a CT of the pelvis showed clitoral soft tissue swelling that was 2×3 centimeters in diamt t eter for clinical and pathological evaluation. Alphatfet t toprotein was 1.1 ng/mL (normal range, 0t10 ng/mL). She had been misdiagnosed as having congenital adt t renal hyperplasia presenting with clitoromegaly, but specific tests (serum cortisol, dehydroepiandrosterone sulfate and testosterone) were normal. Surgical resect t tion of the clitoris was done, but a pathological examit t nation was neglected.
The patient presented to us 4 months later with a recurrent mass at the mons pubis ( Figure 1 ). The mass was hard and about 3×4 centimeters in diameter, fixed to the underlying structures and not the skin, but the overlying skin was hyperemic with dilated vessels, and no enlarged inguinal lymph nodes. Vaginal inspection was free, and the rectal examination was also free. A CT of the pelvis showed hypertrophy of the soft tissue of the clitoris ( Figure 2) . A biopsy was taken from the mass (grayish white, 2×3.5×2 centimeters) and hematoxylin and eosin stain revealed highly pleomorphic small cells with small rounded nuclei and large spindletshaped cells with vesicular nuclei and acidophilic cytoplasm. The tumor cells were disposed in a rich collagenous fit t brous stroma (malignant rounded cell tumor, mostly embryonal rhabdomyosarcoma) (Figure 3) . A desmin stain was positive. Complete surgical excision of the mass was done and the patient received chemotherapy for rhabdomyosarcoma (VAC protocol scheduled for 43 weeks: vincristine, 1.5mg/m2 IV; actinomycin D, 0.015mg/kgm/day IV for 5 days; cyclophosphamide, 2.2gm/m2 IV with mesna). She also received pelvic radiation therapy for 5 weeks. After 10 months, folt t low up MRI revealed the presence of a soft tissue mass (3×4×4.5 centimeters) at the site of the previous opt t eration with invasion to the skin only and no invasion to underlying bone or interior of the pelvis. The patient was surgically operated on again for treatment of this local recurrence.
Rhabdomyosarcoma of the clitoris
DISCUSSION
Clitoromegaly can be either congenital or acquired. The congenital forms are caused by hormonal disturt t bances or intersex states. Usually they are obvious at birth. When the clitoromegaly develops later, the unt t derlying etiology should be explored and acquired causes should also be considered. These acquired forms of clitoromegaly are either hormonal or nonthormonal. In the hormonal causes, an androgen excess is the main contributing factor for the clitoral enlargement. Three groups are generally distinguished: endocrinopathies, masculinizing tumors, or selftinjection of longtacting synthetic androgens, 4 but clitoral tumors should be considered in the differential diagnosis. The clitoris can be involved in a variety of benign and malignant neoplasms. Among the multiple reports of neoplasms involving the clitoris are angiokeratoma, 5, 6 hemangiot t ma, 7 neurotumors associated with neurofibromatosis, 8 keratoacanthoma 9 and lymphoma. 10 In adults, the most common malignancies involve squamous cell carcinot t mas of the vulva that invade the corporal bodies.
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The clitoris is rarely a metastatic site and equally as rare is a primary sarcoma of the vulva that may extend to the clitoris. 13t15 The most common sites of presentation of rhabdot t myosarcoma are genitourinary (29%), parameningeal (24%), the extremities (15%), retroperitoneal (13%), orbit (8%), other head and neck (7%), and miscellat t neous sites (4%). Most often, rhabdomyosarcoma prest t ents as a rapidly enlarging mass lesion, although often the manifestations of tumor growth depend on the prit t mary tumor site. 16 The genitourinary sites of this lesion in younger females are primarily vaginal, cervical, and uterine, with occasional tumor extension to involve the urethra and labia. A lesion that originates superficial to the introitus is rare, although a few cases of vulvar rhabdomyosarcoma exist. 17, 18 Rhabdomyosarcomas arise in primitive fetal mesent t chyme even at sites that do not contain skeletal muscle. It also manifests immunohistochemical expression of myosin, actin, desmin, myoglobin and Ztband protein.
Histologically, there are four subtypes: embryonal, alveolar, botryoid and pleomorphic. 19 The embryot t nal subtype represents about 54% of rhabdomyosart t comas. This subtype usually occurs before 8 years of age and accounts for 80% of genitourinary tumors, 60% of head and neck tumors and 50% of tumors at other sites. The tumor is poorly circumscribed, soft and whitish in color. Morphologically, it resembles the developing skeletal muscle of the 7t10 week old fetus. Rhabdomyoblasts can take several characteristic mort t phologic appearances.
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All patients with rhabdomyosarcoma are presumed to have micrometastatic disease at diagnosis, and thus successful treatment requires achievement of both lot t cal and systemic control of disease. Systemic control is achieved by chemotherapy even for patients with lot t calized disease to eradicate the micrometastasis. The chemotherapy regimens used include a combination of the effective agents in rhabdomyosarcoma, which are cyclophosphamide, ifosfamide, melphalan, actinomyt t cin D, adriamycin, cisplatin, carboplatin, vincristine and etoposide. Local control is accomplished by comt t plete surgical excision and/or local irradiation. 21 Clitoral rhabdomyosarcoma in children is a very rare tumor, reported only in few cases. 22t24 It may have a poor prognosis and may be resistant to treatment due to delay 
